$2995 | Single User
$4495 | Multi User
$8995 | Site License
$14995 | Global License

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017
[Report Updated: 01-11-2017]

Published by Current Partnering: 01 Nov 2017 | 133297 | In Stock
Related Topics: Abbott , AstraZeneca , Lilly , Novartis , Pfizer , Roche

Introduction

The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report.


This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2010 to 2017.


The report provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.


A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.


Manufacturing and supply agreements provide a popular method of maximizing the value of a product launched into a market. The deals allow the product marketer to focus on its sales and marketing efforts whilst relying on a third party to manufacture and supply product on demand, enabling rapid response to market demands. It also ensures that the marketer does not need to invest in costly infrastructure and expertise ahead of knowing whether the product will be successful or sustainable.


Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


This report contains a comprehensive listing of over 2,500 manufacturing and supply deals announced since 2010 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.


Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.


The initial chapters of this report provide an orientation of manufacturing and supply deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in manufacturing and supply deal making as well as a discussion on the merits of the type of deal.


Chapters 3 and 4 provide an overview of the structure of manufacturing and supply deals. The chapter includes numerous case studies to enable understanding of both pure manufacturing and supply deals and multicomponent deals where manufacturing and supply forms a part.


Chapter 5 provides a review of the leading manufacturing and supply deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.


Chapter 6 provides a review of the top 50 most active biopharma companies in manufacturing and supply. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.


Chapter 7 provides a comprehensive and detailed review of manufacturing and supply deals signed and announced since 2010 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.


The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.


The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply deal making since 2010.


In addition, a comprehensive appendix is provided organized by manufacturing and supply company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply partnering in the research, development and commercialization of technologies and products.


Key benefits


Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 provides the reader with the following key benefits:


In-depth understanding of manufacturing and supply deal trends since 2010

Analysis of the structure of manufacturing and supply agreements with numerous real life case studies

Comprehensive access to over 2,500 actual manufacturing and supply deals entered into by the world’s biopharma companies

Detailed access to actual manufacturing and supply deals entered into by the leading fifty bigpharma companies

Comprehensive access to all manufacturing and supply deals entered since 2010

Insight into the terms included in a manufacturing and supply agreement, together with real world clause examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by pharma, biotech, device and diagnostics companies worldwide.


Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 includes:


Trends in manufacturing and supply dealmaking in the biopharma industry since 2010

Analysis of manufacturing and supply deal structure

Case studies of real-life manufacturing and supply deals

Access to over 2,500 manufacturing and supply deal records covering pharma, biotech, devices and diagnostics since 2010

The leading manufacturing and supply deals by value since 2010

Most active manufacturing and supply dealmakers since 2010

The leading manufacturing and supply partnering resources


In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017, the available deals are listed by:


Company A-Z

Headline value

Stage of development at signing

Therapeutic area

Technology type


Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.


The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive access to available records for over 2,500 maufacturing and supply deals, including contract documents where available. Analyzing actual contract agreements allows assessment of the following:


What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Table of Contents
for Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 [Report Updated: 01-11-2017]

  • Executive Summary

    Chapter 1 – Introduction

    Chapter 2 – Trends in manufacturing and supply deal making

    2.1. Introduction

    2.2. Difference between manufacturing and supply deals

    2.3. Trends in manufacturing and supply deals since 2010

    2.3.1. Manufacturing and supply deal making by year since 2010

    2.3.2. Manufacturing and supply deal making by phase of development since 2010

    2.3.3. Manufacturing and supply deal making by industry sector since 2010

    2.3.4. Manufacturing and supply deal making by therapy area since 2010

    2.3.5. Manufacturing and supply deal making by technology type since 2010

    2.3.6. Manufacturing and supply deal making by most active company since 2010

    2.3.7. When supply can be useful

    2.4. Attributes of pure manufacturing and supply deals

    2.5. Attributes of manufacturing and supply in multi-component deals

    2.6. Reasons for including manufacturing and supply options in a multi-component deal

    2.7. The future of manufacture and supply as part of multicomponent deals

    Chapter 3 – Overview of manufacturing and supply deal structure

    3.1. Introduction

    3.2. Pure versus multi-component manufacturing deals

    3.3. Pure manufacturing agreement structure

    3.3.1. Example manufacturing agreements

    3.3.1.a. Case study 1: Amyris Brazil – Biomin Nutricao Animal Do Brasil

    3.3.1.b. Case study 2: Patheon – Orexigen Therapeutics

    3.4. Manufacturing rights as part of a wider alliance agreement

    3.4.1. Example multicomponent manufacturing clauses

    3.4.1.a. Case study 3: Agenus Bio – NewVac

    3.4.1.b. Case study 4: Elite Pharmaceuticals – Hi-Tech Pharmacal

    Chapter 4 – Overview of supply deal structure

    4.1. Introduction

    4.2. Supply agreement structure

    4.2.1. Example supply agreements

    4.2.1.a. Case study 5: Omthera Pharmaceuticals – Catalent Pharma solutions

    4.2.1.b. Case study 6: Endo Pharmaceuticals – Noramco

    4.3. Supply rights as part of a wider alliance agreement

    4.3.1. Example co-marketing right clauses

    4.3.1.a. Case study 7: Auxilium Pharmaceuticals – Asahi Kasei

    4.3.1.b. Case study 8: Durata Therapeutics - Hospira

    Chapter 5 – Leading manufacturing and supply deals

    5.1. Introduction

    5.2. Top manufacturing and supply deals by value

    Chapter 6 – Top 50 most active manufacturing and supply dealmakers

    6.1. Introduction

    6.2. Top 50 most active manufacturing and supply dealmakers

    Chapter 7 – Manufacturing and supply deals contract directory since 2010

    7.1. Introduction

    7.2. Manufacturing and supply deals with contracts since 2010

    Appendices

    Appendix 1 – Manufacturing and supply deals by company A-Z

    Appendix 2 – Manufacturing and supply deals by stage of development

    Appendix 3 - Manufacturing and supply deals by deal type

    Appendix 4 – Manufacturing and supply deals by therapy area

    Appendix 5 – Manufacturing and supply deals by technology type

    Appendix 6 –Deal type definitions

    About Wildwood Ventures

    Current Partnering

    Current Agreements

    Recent report titles from Current Partnering

    TABLE OF FIGURES

    Figure 1: Definition of manufacturing and supply

    Figure 2: Types of manufacturing agreement

    Figure 3: Trends in manufacturing and supply deal announcements since 2010

    Figure 4: Manufacturing and supply deals signed at each phase of development since 2010

    Figure 5: Manufacturing and supply deals by industry sector since 2010

    Figure 6: Manufacturing and supply deals by therapy area since 2010

    Figure 7: Manufacturing and supply deals by technology type since 2010

    Figure 8: Top 50 most active manufacturing and supply dealmakers since 2010

    Figure 9: Components of the manufacturing deal structure

    Figure 10: Components of the supply deal structure

    Figure 11: Top manufacturing and supply deals by value since 2010

    Figure 12: Most active manufacturing and supply dealmakers since 2010

Additional Details

Publisher

Current Partnering

Publisher Information

Reference

133297 | CP2053

Number of Pages

1600

Report Format

PDF

Current Partnering Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Murata Manufacturing Co., Ltd. (6981) - Medical Equipment - Deals and Alliances Profile
SummaryMurata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that...
21 Jul 2016 by Global Data USD $250 More Info
Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group i...
10 May 2016 by Global Data USD $250 More Info
Jordanian Pharmaceutical Manufacturing Co. PLC (JPHM) - Financial and Strategic SWOT Analysis Review
SummaryJordanian Pharmaceutical Manufacturing Co. PLC (JPM) is an integrated pharmaceutical company ...
15 Apr 2016 by Global Data USD $300 More Info
Advanced Integrated Manufacturing Corp. Ltd (AXH) - Financial and Strategic SWOT Analysis Review
SummaryAdvanced Integrated Manufacturing Corp. Ltd. (Aimcorp) is an electronics manufacturing servic...
15 Apr 2016 by Global Data USD $300 More Info
European Medical Contract Manufacturing B.V. - Medical Equipment - Deals and Alliances Profile
SummaryEuropean Medical Contract Manufacturing B.V. (EMCM B.V.), a subsidiary of aap Implantate AG i...
13 Apr 2016 by Global Data USD $250 More Info
Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group i...
16 Mar 2016 by Global Data USD $250 More Info
European Medical Contract Manufacturing B.V. - Medical Equipment - Deals and Alliances Profile
SummaryEuropean Medical Contract Manufacturing B.V. (EMCM B.V.), a subsidiary of aap Implantate AG i...
24 Feb 2016 by Global Data USD $250 More Info
Advanced Integrated Manufacturing Corp. Ltd (AXH) - Financial and Strategic SWOT Analysis Review
SummaryAdvanced Integrated Manufacturing Corp. Ltd. (Aimcorp) is an electronics manufacturing servic...
09 Jan 2016 by Global Data USD $300 More Info
Advanced Integrated Manufacturing Corp. Ltd (AXH) - Financial and Strategic SWOT Analysis Review
SummaryAdvanced Integrated Manufacturing Corp. Ltd. (Aimcorp) is an electronics manufacturing servic...
08 Nov 2015 by Global Data USD $300 More Info
European Medical Contract Manufacturing B.V. - Medical Equipment - Deals and Alliances Profile
SummaryEuropean Medical Contract Manufacturing B.V. (EMCM), a subsidiary of aap Implantate AG is med...
16 Oct 2015 by Global Data USD $250 More Info

This report is published by Current Partnering

Download Free Report Summary PDF

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 [Report Updated: 01-11-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)